Home > Products > CD33 & CD64
> Recombinant Anti-CD33 x Anti-CD64 Bispecific Antibody (Tandem scFv)
Recombinant Anti-CD33 x Anti-CD64 Bispecific Antibody (Tandem scFv) (CAT#: BSFV-115)
Recombinant Anti-CD33 x Anti-CD64 Bispecific Antibody (Tandem scFv) is designed to be expressed as a scFv from an anti-CD33 antibody variable domains fused with a scFv from an anti-CD64 antibody variable domains. It contains a His-tag at the C/N terminus for affinity purification. The BsAb exits as monomer in reducing and non-reducing conditions. This BsAb can retarget neutrophils cells to tumor cells. It is designed for the research of Acute myeloid leukemia (AML); Ulcerative Colitis (UC); Myelodysplastic syndromes (MDS); Gastric cancer therapy.
FCGR1A; Fc fragment of IgG receptor Ia; CD64; FCRI; CD64A; IGFR1; Cluster of Differentiation 64; FcγRI; FCGR1B; FCGR1C; immunoglobulin G Fc receptor high affinity I; Fc gamma RI
Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.
There are currently no customer reviews or questions for Recombinant Anti-CD33 x Anti-CD64 Bispecific Antibody (Tandem scFv) (BSFV-115). Click the button below to contact us or submit your feedback about this product.